These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 34170841)

  • 41. Pain and discomfort in closure of femoral access coronary angiography. The CLOSuredEvices Used in everyday Practice (CLOSE-UP) pain sub study.
    Sindberg B; Schou M; Hansen L; Christiansen KJ; Jørgensen KS; Søltoft M; Holm NR; Maeng M; Kristensen SD; Lassen JF
    Eur J Cardiovasc Nurs; 2014 Jun; 13(3):221-6. PubMed ID: 23532433
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Korean single-center experience with femoral access closure using the ExoSeal device.
    Han Y; Kwon JH; Park S
    World J Radiol; 2018 Sep; 10(9):108-115. PubMed ID: 30310545
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of a Pure Plug-Based Versus a Primary Suture-Based Vascular Closure Device Strategy for Transfemoral Transcatheter Aortic Valve Replacement: The CHOICE-CLOSURE Randomized Clinical Trial.
    Abdel-Wahab M; Hartung P; Dumpies O; Obradovic D; Wilde J; Majunke N; Boekstegers P; Müller R; Seyfarth M; Vorpahl M; Kiefer P; Noack T; Leontyev S; Sandri M; Rotta Detto Loria J; Kitamura M; Borger MA; Funkat AK; Hohenstein S; Desch S; Holzhey D; Thiele H;
    Circulation; 2022 Jan; 145(3):170-183. PubMed ID: 34738828
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Use of ExoSeal Vascular Closure Device for Direct Antegrade Superficial Femoral Artery Puncture Site Hemostasis.
    Rimon U; Khaitovich B; Yakubovich D; Bensaid P; Golan G; Silverberg D
    Cardiovasc Intervent Radiol; 2015 Jun; 38(3):560-4. PubMed ID: 25209597
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Femoral vascular closure device use, bivalirudin anticoagulation, and bleeding after primary angioplasty for STEMI: results from the HORIZONS-AMI trial.
    Sanborn TA; Tomey MI; Mehran R; Généreux P; Witzenbichler B; Brener SJ; Kirtane AJ; McAndrew TC; Kornowski R; Dudek D; Nikolsky E; Stone GW
    Catheter Cardiovasc Interv; 2015 Feb; 85(3):371-9. PubMed ID: 25179260
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Arterial access-site complications after use of a vascular closure device related to puncture height.
    Sartorius B; Behnes M; Ünsal M; Hoffmann U; Lang S; Mashayekhi K; Borggrefe M; Akin I
    BMC Cardiovasc Disord; 2017 Feb; 17(1):64. PubMed ID: 28209184
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A Retrospective Study Comparing the Effectiveness and Safety of EXOSEAL Vascular Closure Device to Manual Compression in Patients Undergoing Percutaneous Transbrachial Procedures.
    Wei X; Han T; Sun Y; Sun X; Wu Y; Wang S; Zhou J; Zhao Z; Jing Z
    Ann Vasc Surg; 2020 Jan; 62():310-317. PubMed ID: 31449959
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Vascular complications with a plug-based vascular closure device after transcatheter aortic valve replacement: Predictors and bail-outs.
    van Wiechen MP; Kroon H; Hokken TW; Ooms JF; de Ronde-Tillmans MJ; Daemen J; de Jaegere PP; Van Mieghem NM
    Catheter Cardiovasc Interv; 2021 Nov; 98(5):E737-E745. PubMed ID: 33533544
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Vascular access complications after catheter ablation of ventricular arrhythmias: Impact of vascular closure devices.
    Tabaja C; Hight N; Younis A; Jadam S; Demian J; Hussein A; Sroubek J; Saliba W; Kanj M; Bhargava M; Baranowski B; Callahan T; Chung M; Dresing T; Lee J; Higuchi K; Liuba I; Martin D; Nakhla S; Rickard J; Varma N; Taigen T; Wazni O; Santangeli P
    Heart Rhythm; 2024 Sep; ():. PubMed ID: 39245246
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of manual compression, Z-stitch, and suture-mediated vascular closure device techniques in dogs undergoing percutaneous transvenous intervention.
    Fabella A; Markovic LE; Coleman AE
    J Vet Cardiol; 2024 Feb; 51():124-137. PubMed ID: 38128418
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Percutaneous Plug-Based Arteriotomy Closure Device for Large-Bore Access: A Multicenter Prospective Study.
    Van Mieghem NM; Latib A; van der Heyden J; van Gils L; Daemen J; Sorzano T; Ligthart J; Witberg K; de Kroon T; Maor N; Mangieri A; Montorfano M; de Jaegere PP; Colombo A; Roubin G
    JACC Cardiovasc Interv; 2017 Mar; 10(6):613-619. PubMed ID: 28335899
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mynx vascular closure device achieves reliable closure and hemostasis of percutaneous transfemoral venous access in a porcine vascular model.
    Srivatsa SS; Srivatsa A; Spangler TA
    J Invasive Cardiol; 2015 Feb; 27(2):121-7. PubMed ID: 25661765
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Single Angio-Seal vascular closure device for transfemoral access exceeding 8F.
    Frenzel F; Fries P; Shayesteh-Kheslat R; Buecker A; Massmann A
    J Cardiol; 2020 Aug; 76(2):211-216. PubMed ID: 32402666
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Propensity-matched comparison of large-bore access closure in transcatheter aortic valve replacement using MANTA versus Perclose: A real-world experience.
    Medranda GA; Case BC; Zhang C; Rappaport H; Weissman G; Bernardo NL; Satler LF; Ben-Dor I; Rogers T; Waksman R
    Catheter Cardiovasc Interv; 2021 Sep; 98(3):580-585. PubMed ID: 34051039
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bleeding and vascular complications at the femoral access site following percutaneous coronary intervention (PCI): an evaluation of hemostasis strategies.
    Tavris DR; Wang Y; Jacobs S; Gallauresi B; Curtis J; Messenger J; Resnic FS; Fitzgerald S
    J Invasive Cardiol; 2012 Jul; 24(7):328-34. PubMed ID: 22781471
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Vascular Closure Devices versus Manual Compression in Cardiac Interventional Procedures: Systematic Review and Meta-Analysis.
    Pang N; Gao J; Zhang B; Guo M; Zhang N; Sun M; Wang R
    Cardiovasc Ther; 2022; 2022():8569188. PubMed ID: 36134143
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Safety and Efficacy of Arterial Closure Devices Following Antegrade Femoral Access: A Case-Control Study.
    Barrette LX; Vance AZ; Mantell MP; Kratz KM; Redmond JW; Clark TWI
    Vasc Endovascular Surg; 2020 Oct; 54(7):612-617. PubMed ID: 32721190
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of radial access versus femoral access with the use of a vascular closure device for the prevention of vascular complications and mortality after percutaneous coronary intervention.
    Téblick A; Vanderbruggen W; Vandendriessche T; Bosmans J; Haine SEF; Miljoen H; Segers V; Wouters K; Vrints C; Claeys MJ
    Acta Cardiol; 2018 Jun; 73(3):241-247. PubMed ID: 28851255
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A novel double clip-based vascular closure device in antegrade and retrograde femoral punctures: A single-center experience in peripheral non-cardiac procedures.
    Thurner A; Heuer A; Augustin AM; Gietzen C; Bley TA; Kickuth R
    J Vasc Access; 2022 Sep; 23(5):778-787. PubMed ID: 33908308
    [TBL] [Abstract][Full Text] [Related]  

  • 60. AbsorbaSeal™ Vascular Closure Device: A Novel Device for Hemostasis Following Interventional Peripheral Vascular Procedures.
    Benham E; Deloose K; Callaert J; Bosiers M; Cox T; Lincourt A; Heniford BT
    Surg Technol Int; 2017 Oct; 31():93-99. PubMed ID: 29020709
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.